which said it remains committed to brining the drug to patients with the inflammatory condition, which results in the growth of nasal polyps in the nose that can sometimes require surgical ...
CRSwNP is an inflammatory condition which results in the growth of nasal polyps in the nose that can sometimes require surgical intervention. Around 40% of cases are uncontrolled and – in severe ...
5don MSN
A new CT-scan-based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to ...
Upstream Bio’s (NASDAQ:UPB – Get Free Report) lock-up period will end on Wednesday, April 9th. Upstream Bio had issued 15,000,000 shares in its initial public offering on October 11th. The total size ...
In the polypoid form of the disease, mucosal protrusions, or polyps, block the nasal and sinus cavities ... is based on inflammatory findings in the sinus mucosa, and on the obstruction of ...
News-Medical.Net on MSN5d
New CT-based score helps predict need for repeat sinus surgeryA new CT-scan based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to ...
Learn more about whether Alvotech or Veracyte, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Learn more about whether ACADIA Pharmaceuticals Inc. or Alvotech is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback